G Boss
SVP Strategy and Business DevelopmentÂ
TherapeuticsMD, Inc.
Germany
Biography
Greg is responsible for worldwide legal operations for all CSL Limited Group companies. CSL is a global biotechnology leader with business operations in more than 60 countries, and Greg has served as Group General Counsel since 2009. He is a member of the Executive Global Leadership Group, and he serves as Secretary to the Board’s Audit and Risk Management Committee.Greg joined CSL in 2001, serving as U.S. General Counsel for CSL’s sales and distribution business, ZLB Bioplasma. In this role, he was instrumental in the company’s acquisition and integration of competitor Aventis Behring, and upon the integration of the two companies in 2004, Greg assumed the General Counsel position for the combined business.In January 2009, Greg was appointed to the role of Group General Counsel for CSL Limited, an Australian Stock Exchange-listed company headquartered in Melbourne, Australia. Greg is based in King of Prussia, Pennsylvania, and oversees legal operations globally. In addition, Greg is responsible for Risk Management, Compliance and Corporate Communications.Among his industry recognitions as a global leader, Greg received the World Recognition of Distinguished General Counsel from the Directors Roundtable in 2016 in acknowledgment of his professional accomplishments and passion for ethical leadership.
Research Interest
Finance and Business Economics
